Condition: Implant Complication · Implant Infection · Implant Site Infection · Sponsor: Mikkel Herly
The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in decreasing all-cause implant explantation after breast reconstruction.
This description comes directly from the study's public registry record.
Mikkel Herly, MD, Ph.D. · +45 27598919 · mikkel.herly@regionh.dk
Mathilde Hemmingsen, MD · +45 28568205 · mathilde.nejrup.hemmingsen@regionh.dk
Always discuss trial participation with your own doctor first.
| Aalborg University Hospital | Aalborg, Denmark | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| South-West Jutland Hospital | Esbjerg, Denmark | Not Yet Recruiting |
| Herlev and Gentofte Hospital | Herlev, Denmark | Recruiting |
| Odense University Hospital | Odense, Denmark | Recruiting |
| Zealand University Hospital | Roskilde, Denmark | Recruiting |
| Vejle Hospital | Vejle, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04731025